Bikaji Foods International Limited (BIKAJI)

Fast Moving Consumer Goods · Food Products · NSE · Updated 2 August 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹641.65 ↓ 14.97% (1Y)

🎯 Key Takeaways

Bikaji Foods International Limited is in a strategic expansion and consolidation phase, marked by recent acquisitions, leadership continuity through re-appointments, and active investment in international markets. The company is transitioning from a high-margin, smaller-scale operator to a broader FMCG player with diversified product lines and geographic reach, though profitability has shown recent volatility.
Revenue declined 0.9% QoQ to ₹715 in Q3FY25.
⚠️ 1) Margin compression in Q3FY25 raises concerns about sustainability of profitability amid expansion. 2) Integration risks from recent acquisitions li

Market Cap

₹16,776

P/E Ratio

61.5

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About BIKAJI 📊 Interactive Charts

📖 The Story

Bikaji Foods International Limited is in a strategic expansion and consolidation phase, marked by recent acquisitions, leadership continuity through re-appointments, and active investment in international markets. The company is transitioning from a high-margin, smaller-scale operator to a broader FMCG player with diversified product lines and geographic reach, though profitability has shown recent volatility.

📰 What's Happening

In Q3FY26, Bikaji completed the acquisition of 74% of JBDSPL, expanding its snack manufacturing footprint in Chhattisgarh, and invested $29 lakh in Bikaji USA to scale US manufacturing. The Board re-appointed key directors including Deepak and Shweta Agarwal for three-year terms ending 2030, signaling leadership stability. A final dividend of ₹1.25 per share was declared at the upcoming AGM, reflecting confidence in cash flow. Additionally, the company raised capital through instruments like Optionally Convertible Debentures (OCDs) to fund BBPL, indicating active capital deployment for growth.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	462	482	609	624	614	572	721	715
Operating Profit	66	71	94	81	173	99	115	63
OPM %	13.4%	13.7%	14.4%	12.0%	26.2%	16.0%	14.8%	7.8%
Net Profit	38	41	60	46	116	58	69	28
EPS	₹1.51	₹1.67	₹2.45	₹1.87	₹4.64	₹2.34	₹2.76	₹1.14

The company's revenue peaked in Q4FY24 at ₹614 crore with strong margins (OPM 26.2%), but Q3FY25 showed a sharp decline in both revenue (₹715 crore) and margins (OPM 7.8%), with operating profit dropping from ₹173 crore to ₹63 crore. This suggests seasonal softness or transitional pressures, possibly linked to integration costs or market dynamics post-acquisitions. Despite revenue growth from ₹482 crore in Q1FY24 to ₹715 crore in Q3FY25, profitability has not improved proportionally, indicating rising cost pressures or investment outflows impacting margins.

🔮 Management Outlook & What's Next

Management has not provided forward guidance in the latest filings, but past communications indicate confidence in growth through strategic acquisitions and international expansion. The re-appointment of leadership and dividend declaration suggest a focus on long-term stability and shareholder returns. Capital allocation efforts, including investments in US and subsidiary funding via debt guarantees, reflect a clear strategy to scale operations, though near-term profitability may remain pressured during integration phases.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Food Products

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Nestle India Limited	2.76 L Cr	84.6	93.6%	81.3%	0.19
Britannia Industries Limited	1.30 L Cr	53.9	60.6%	55.5%	0.28
Hatsun Agro Product Limited	20,977	60.2	—	—	—
Avanti Feeds Limited	18,028	37.5	—	—	—
Bikaji Foods International Limited	16,776	61.5	—	—	—
Zydus Wellness Limited	15,976	49.1	—	—	—
EID Parry India Limited	14,042	9.2	—	—	—
Godrej Agrovet Limited	10,960	26.3	—	—	—
The Bombay Burmah Trading Corporation Limited	10,625	5.0	—	—	—
Orkla India Limited	8,647	—	—	—	—

🔗 Peer Stock Analyses

NESTLEIND BRITANNIA HATSUN AVANTIFEED ZYDUSWELL

⚠️ Risk Factors

1) Margin compression in Q3FY25 raises concerns about sustainability of profitability amid expansion. 2) Integration risks from recent acquisitions like JBDSPL and US operations could strain cash flows. 3) High capital expenditure on international ventures may pressure balance sheet if returns are delayed. 4) Lack of transparent forward guidance introduces uncertainty around execution of growth strategy.

📋 Recent Filings

🧠 Analyst's Read

Bikaji is executing a clear but capital-intensive growth strategy through acquisitions and geographic expansion, with management signaling confidence via dividend and leadership continuity. Investors should monitor the upcoming earnings call for margin trends, integration progress, and updated capital allocation plans, as near-term profitability may remain volatile despite revenue growth.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on BIKAJI

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-02.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BIKAJI files new disclosures

Track BIKAJI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BIKAJI — Free

Free account · 2 AI queries/day